ProfileGDS5678 / 1434937_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 97% 98% 98% 97% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.114598
GSM967853U87-EV human glioblastoma xenograft - Control 29.664197
GSM967854U87-EV human glioblastoma xenograft - Control 39.8749698
GSM967855U87-EV human glioblastoma xenograft - Control 410.135998
GSM967856U87-EV human glioblastoma xenograft - Control 59.6926597
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.8475898
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.231198
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.033698
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.9366498
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.9388398
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.613398
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.183598
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.9515498
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.8962998